Left ventricular hypertrophy (LVH) is a common pathologic finding. Approximately 20% of the population of 50-year-olds, with an increasing percentage in older people, experience LVH. It represents an independent predictor of premature death, which is about as clinically important as frequent ventricular premature beats. The enhanced risk is attributed to consecutive malignant ventricular arrhythmias and to heart failure. It is possible to prevent or reduce LVH with drugs such as angiotensin-converting enzyme inhibitors, thus eliminating or diminishing the fatal consequences. Therefore, the reliable diagnosis of LVH has gained increased interest during the last two decades.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Rights and permissions
Copyright information
© 2009 Springer-Verlag London Limited
About this chapter
Cite this chapter
(2009). Left Ventricular Hypertrophy. In: The ECG Manual. Springer, London. https://doi.org/10.1007/978-1-84800-171-8_5
Download citation
DOI: https://doi.org/10.1007/978-1-84800-171-8_5
Publisher Name: Springer, London
Print ISBN: 978-1-84800-170-1
Online ISBN: 978-1-84800-171-8
eBook Packages: MedicineMedicine (R0)